Mark Germain serves as the Chairman of the Board of Directors at Scinai Immunotherapeutics Ltd., a biopharmaceutical company focused on innovative products for infectious diseases. As the Managing Director of The Aentib Group since 2014, Germain directs a global advisory and investment firm specializing in tailored solutions for corporate and private equity clients. Additionally, Germain holds advisory roles at Lunit and chairs the Board of Directors at HerronTech, a company developing advanced software platforms. With a history of co-founding numerous biotech companies, including Alexion, Incyte, and ChromaDex, Germain has played a pivotal role in company formation and strategic decision-making. Germain holds a JD from New York University School of Law.
This person is not in the org chart
This person is not in any teams
This person is not in any offices